About
Leadership
Board of Directors
Scientific Advisors
Careers
Contact Us
Technology
Publications
Collaborations
Pipeline & Clinical Trials
FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
FCX-013 Gene Therapy for Localized Scleroderma
Gene Therapy Research Program for Arthritis and Related Conditions
Clinical Trials
Investors
Stock Information
News, Events & Presentations
SEC Filings
Corporate Governance
Analyst Coverage
Investor FAQs
Investor Contacts
Patients & Families
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Localized Scleroderma
Arthritis and Related Conditions
News, Events &
Presentations
Contact
Toggle navigation
SEC Filings
Investors
|
SEC Filings
Back
Form 4
FIBROCELL SCIENCE, INC. filed this
Form 4
on 12/13/2017
Document Outline
Entire Document (16.6 KB)
Subdocument 1 - 4 - FORM 4
